Cardiovascular Effects of Anatoxin-A in the Conscious Rat. SJREN, A.-L., AND FEUERSTEIN, G. (1990). Toxicol. Appl. Pharmacol. 102,91-100. The effects ofanatoxin-A on mean arterial pressure (MAP), heart rate, cardiac index (CI), and blood flow (BF) in hindquarter (HQ), renal (R). and mesenteric (M) vascular beds were studied after intravenous (iv) and intracerebroventricular (icv) administration in the conscious rat. The pharmacological profile of anatoxin-A was further compared to nicotine administered iv and icv. MAP and heart rate were measured from femoral artery, CI by thermodilution method, and blood flow by Doppler velocimetry. Anatoxin-A and nicotine (30, 100 and 300 1-!g/kg iv) produced an increase in MAP with concomitant bradycardia. The highest doses increased Cl. MBF and RBF decreased due to a vasoconstriction in M and R vasculature. These effects were attenuated by the ganglion blocker chlorisondamine (5 mg/kg, iv). Anatoxin-A ( 100 1-!g/k~ iv) increased plasma epinephrine Ievels by 2-fold with virtually no effect on norepinephrine whereas nicotine ( 100 ~oLg/kg, iv) increased plasma epinephrine and norepinephrine by 20-to 30-fold. Central administration of anatoxin-A and nicotine (30-100 ,ug/kg icv) increased MAP with no effect on heart rate and produced M and R vasoconstriction. In summary, the present study demonstrates that anatoxin-A acts as a nicotinic cholinergic agonist in the c.onscious rat after both systemic and centrat administration. Anatoxin-A and nicotine produced pressor and reno-splanchnic vasoconstrictor responses and at high doses increased cardiac output. These effects were mediated by activation ofthe nicotinic receptors in the adrenal medulla and sympathetic ganglia. However, marked differences were found in the potency ofanatoxin-A versus nicotine to stimulate the sympathoadrenomedullary axis. ti;l 1990 Academic Press,lnc.
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Anatoxin-A is a natural toxin isolated from the blue green algae Anabena flos-aquae (Devlin et al.. 1977) . This toxin is produced in freshwater algal blooms and is responsible for the death of livestock and waterfowl via a depolarizing blockade of neuromuscular transmission and subsequent respiratory paralysis (Carmichael et al., 1975) . Anatoxin-A is found to be a stereospecific agonist of nicotinic receptors in frog muscle and torpedo electric organs (Swanson et al., 1986) . lt has also been shown to act upon ganglionic muscarinic and nicotinic receptors of the guinea pig ileum (Carmichael et al .. 1979) and to bind. to nicotinic cholinergic receptors in the rat brain homogenates (Zhang et al., 1987) .
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In the present study we evaluated whether anatoxin-A will produce similar effects to those of nicotine also in an in vivo system. Therefore the effects of anatoxin-A and nicotine on cardiac function and regional blood flow were studied after systemic (intravenous) and central (intracerebroventricular) administration in the conscious rat.
plastic cages (21 x 27 x 16 cm. W X L X H) with food and water ad libitum.
Measurement of cardiac output. The cardiac output was measured by thermodilution technique as previously described in detail (Siren et al.. 1988 ) . Each rat to undergo cardiac output measurements was anesthetized with an intramuscular injection ofketamine ( 130 mg/kg) and acepromazine ( 1.3 mg/kg) and a PE-50 catheter was inserted into the left femoral artery. The catheters were tunneled under the skin and exited at the nape of the neck. An incision was made at the midline of the neck from the cricoid to the da viele. and a PE-50 catheter was inserted into the right atrium via the extemal jugular vein. The )eft common carotid artery was exposed and ligated, and a thermistor (MX2-780-33 Model THMP f 1.5. Teflon reusable. Columbus Instruments, OH) was advanced through the carotid into the ascending aorta. Placement above the aortic valve was confirmed in each animal by the shape of the dilution curve before the probe was finally sutured to the neck musdes and again at the end of experiment. The jugular vein catheter and the thermistor Ieads were tunneled under the skin to the nape of the neck. All catheters and the probe wire were secured by a soft spring wire attached to the animal's neck using an adhesive collar. Twenty-four hours after the surgery, the arterialline was connected to a pressure transducer (Narco Bio-Systems Model RP 1500i) attached to a strain gauge coupler (Narco Bio-Systems Type 7032). Blood pressure (mean, systolic, diastolic, pulse) and heart rate were continuously recorded on a Narcotrace 80 computerized physiograph and sampled automatically at 30-to 60-sec intervals by a NorthstarHazeltine computer.
T o obtain measurements of cardiac output. the aortic thermistorwas attached to the computerized Cardiomax II (CMX2-780-k with microprobe option R. Columbus Instruments, OH). The dead space ofthe venous Jine was first flushed with 50 ~I of 0.9% (w/v) NaCl (saline) at room temperature (22°C). After a brief stabilization period an additional injection of 200 ~~ normal saline czrc) was rapidly injected into the right atrium using a 1-ml syringe, and the blood temperature was monitared by the aortic thermistor. The thermodilution curve representing the change in aortic temperature was then calculated by the Cardiomax II. A control period of 15 min included two or three cardiac output recordings to test for consistency and p]acement ofthe probe. During this time period. control values for blood pressure and heart rate also were collected. The timer for automatic data collection was started and data points for blood pressure. heart rate. and cardiac output were collected immediately before and I. 5, 15, 30. and 45 min after anatoxin-A or nicotine injection into the jugular catheter. Total peripheral resistance (TPR) was calculated by dividing the mean arterial pressure by the cardiac output and values of cardiac output and TPR were further indexed per unit ofweight (kg). Core temperature was monitared by the aortic thermoprobe before each cardiac output measurement.
Measurement oforgan bloodjlow.
Regional blood flow in hindquarter, renal. and mesenteric arteries was monitared in a separate group of rats by using the directional pulsed Doppler technique. Although it does not allow for quantitative blood flow monitoring. this method is superior to other available techniques. since ( 1 ) it can be used chronically in conscious animals~ (2) it allows continuous on-line recording ofblood flow. and (3) it can detect instantaneous. transient changes in blood tlow within seconds after drug administration. Haywood and coworkers ( 1981) demonstrated that the velocity signals recorded from the Doppler flow probes are directly and reliably proportional to changes in true volume flow measured by electromagnetic flowmetry.
Each rat to undergo regional hemodynamic measurements was anesthetized with ketamine-acepromazine. and a guide cannula for icv injections was placed on the skull as described below. A midline laparotomy was then made. and the left renal and superior mesenteric arteries and lower atxlominal aorta above its bifurcation were carefully isolated under a dissecting microscope. Doppler flow probes (Valpey-Fisher, Hopkinton, MA) were then loosely sutured araund each vessel as described earlier (Haywood et al.. 1981 ~ Siren and Feuerstein, 1986~ Siren et al.. 1988 . The insulated wire Ieads were fixed to the back musdes. tunneled under the back skin to exit at the neck. and soldered to a receptacle which was then attached to the skull using small screws and dental acrylic. The animals were allowed to recover from the surgery for 7 days. Twenty-four hours before the experiment the rat was reanesthetized with halothane (2% in oxygen) and femoral artery and vein were catheterized with PE-50 tubing. The catheters were tunneled under the back skin. exited at the nape ofthe neck, and secured by a soft spring wire as described above.
On the day ofthe experiment, the arterial catheter was connected to a pressure transducer (Narco) and blood pressure and heart rate were continuously recorded on the Narcotrace 80 physiograph. A cable connecting the blood flow receptacle and the Doppler flowmeter (University of lowa, Bioengineering Facility, Model 545C-4) was attached to the animaland the mean blood flow continuously recorded on the physiograph. Vascular resistance was calculated by dividing the mean arterial pressure by blood velocity (Doppler shift in kilohertz) as earlier described (Haywood et a/.. 1981; Siren et al.. 1988; Siren and Feuerstein, 1986) . Changes in blood flow and vascular resistance are expressed as a percentage of control values.
Intracerehroventricular injections.
Rats were anesthetized with ketamine-acepromazine (see above) and placed on a Stereotaxie device (David Kopflnstruments. CA). A stainless-steel guide cannula was inserted through the skull and fixed with glue (Eastman 910 adhesive). Coordinates for the injections into the right lateral brain ventricle (icv) were measured from the bregma: AP = -0.8 mm and L = 1.2 mm. After the placement ofthe icv cannula. implantation of Doppler flow probes and femoral catheters was done as described in detail in the previous paragraph (Measurement of organ blood flow). On the day ofthe experiment, drug injections were made using a premeasured 30 g (7 .5 mm) cannula inserted into the ventricular space through the guide cannula. Theinjection cannula was then connected via polyethylene tubing to a Hamitton microliter syringe, and a volume of 10 J.Ll of the control or drug solution was injected over a period of 30 sec. The proper position of the icv cannula was determined at the end of each experiment by an injection of dye (methylene blue) into the cerebral ventricles.
Assay of plasma catecholamines. Blood samples (0.8 ml) were withdrawn from the arterial catheter 30 min after the iv administration of anatoxin-A or nicotine ( 100 ILg/kg). The blood withdrawn was replaced with an equal volume ofheparinized fresh rat blood (10 U.S. units/ml blood). The blood specimens were collected in chilled test tubes and centrifuged (Beckman microfuge B) for 1 min, and the plasma was removed and rapidly frozen on dry ice. Epinephrine (EPI) and norepinephrine (NE) were separated by alumina extraction and assayed by high-performance liquid chromatography with electrochemical detection (Goldstein et al., 1985; Eisenhofer et al .. 1986) .
Statistical analysis ofthe data. Data in text and figures are (means + SE) for the given number of rats. Analysis of variance (ANOV A) with repeated measures (BMD P2V) (Dixon and Brown. 1979 ) and ANOV A with Dunnett's test were used for statistical analysis ofthe data. Drugs used. (±)Anatoxin-A was synthesized by Dr. Rick L. Danheiser (MIT) (Danheiser et a/., 1985) . The stock solution dissolved in ethanol was stored at -20DC under argon until used. The drug dilutions were made in physiological saline (0. 9%) immediately before each injection. Nicotine (Sigma) and chlorisondamine (CibaGeigy) were dissolved in saline.
RESULTS

Systemic Effects of Anatoxin-A and Nicotine
Effects on blood pressure and heart rate. Anatoxin-A and nicotine were injected intravenously at doses of 10, 30, 100, and 300 IJ.g/ kg. At the two high er doses both anatoxin-A and nicotine produced dose-related increases in mean arterial pressure (Fig. 1 ) . The effect became apparent immediately after the injection reached its maximum within 1-2 min, and completely subsided in 5-10 min. Low doses of anatoxin-A tended to increase heart rate while high doses elicited bradycardia (heart rate decreased more than 100 bpm). Nicotine at the 1 00 ,ug/kg dose increased heart rate while the 300 1-Lg/kg dose reduced heart rate.
Effects on cardiac index and total peripheral resistance index (TPRI) . The effect of anatoxin-A and nicotine on cardiac index and TPRI are presented in Fig. 2 . At the 1 00 1-Lg/kg dose anatoxin-A or nicotine bad no effect on cardiac index. At the highest dose (300 1-Lg/kg) anatoxin-A induced a transient increase in cardiac output. Nicotine at this dose first decreased (phase I) and then 5 min after the injection (phase II) increased cardiac output. The initial phase I of the nicotine effect was accompanied by an increase in TPRI but resistance remained unchanged during phase II ofthe nicotine response.
Effects on regional bloodflow and vascular resistance. The hindquarter blood flow was increased by anatoxin-A or nicotine doses of 1 00 and 300 f!g/kg, but the vascular resistance in the hindquarter vascular bed was not changed (Fig. 3 ) . In the renal (Fig. 4) and particularly mesenteric (Fig. 5) blood vessels both anatoxin-A and nicotine produced vasoconstriction as evidence by decreased blood flow and increased vascular resistance.
Role ofthe Autonomie Nervous System
The rote of sympathetic nervous system in mediating cardiovascular responses to anatoxin-A was studied (I) by monitaring plasma catecholamines after anatoxin-A and nicotine administration and (2) by treating the rats with the ganglionic blocker chlorisondamine.
~}j'ect of anatoxin-A and nicotine an plasma catecholanzines. Anatoxin-A at the dose of 1 00 f!g/kg produced a 2-fold increase in plasma epinephrine but had no significant effect on plasma norepinephrine Ievels (Fig.  6) . The corresponding dose of nicotine increased both epinephrine and norepinephrine by 20-to 30-fold (Fig. 6 ) .
Jnjluence o.f chlorisondamine. Chlorisondamine (5 mg/kg iv) completely blocked the pressor effect of anatoxin-A ( l 00 JLg/kg) and reduced the tachycardic response (Fig. 7) . The decrease in hindquarter blood flow by anatoxin-A was totally blocked after chlorisondamine while the flow in renal and mesenteric beds was still decreased by anatoxin-A administration in the chlorisondaminetreated rats (Fig. 7) . The increase in vascular resistance by anatoxin-A in the all these vas- Chlorisondamine reversed the pressor effect of nicotine ( l 00 ~g/kg) and attenuated the tachycardia produced by nicotine (Fig. 8) . Nicotine decreased blood flow in hindquarter, renal, and mesenteric vascular beds in chlorisondamine-treated rats but the decrease in flow was not due to active vasoconstriction since no increase in vascular resistance was produced by nicotine after chlorisondamine treatment (Fig. 8) .
Central Effects qf Anatoxin-A and Nicotine
Effects on blood pressure and heart rate. Intracerebroventricular administration of anatoxin-A at the dose of 100 ~g/kg increased blood pressure (Fig. 9) . Nicotine at doses of 30 and I 00 J.Lg/kg induced a dose-related hypertensive response (Fig. 9) . The heart rate was not significantly altered by icv-administered anatoxin-A or nicotine.
Effects on regional bloodflow and vascular resistance. The blood flow and vascular resistance in hindquarters did not significantly change after icv administration of anatoxin-A or nicotine (Fig. 10) . Renal blood flow was decreased and the renal vascular resistance increased after the icv doses of I 0 and 30 ~gj kg of anatoxin-A and of 10 and 100 JLg/kg of nicotine (Fig. 1 0) . The decrease in renal blood flow after the 30 ~g/kg dose of nicotine (not displayed in Fig. 10 ) was-32 ± 10% (n = 2). The corresponding increase in renal resistance at this dose was + 71 ± 44% (n = 2). creased and the mesenteric vascular resistance increased after the I 00 Jtg/kg dose of anatoxin-A and the 30 and 100 1-Lg/kg doses of nicotine (Fig. 1 0) .
DISCUSSION
The present results demoostrate that anatoxin-A and nicotine produce potent cardiovascular changes after both systemic and centrat nervaus system administration. Intravenous administration of anatoxin-A or nicotine (100-300 Jtg/kg) induced a pressor response (Fig. 1 ) . Vasoconstriction in renal and mesenteric circulation most likely contributed to the increase in blood pressure since the vascular resistance in these blood vessels was significantly increased at the peak of the pressor response (Figs. 3-5) . The potency of the constrictor response was more than threefold greater in the mesenteric (Fig. 5 ) than in the renal (Fig. 4) blood vessels indicating most probably the capacity of the renal vasculature to autoregulate its blood flow .
At the highest doses of anatoxin-A and nicotine an increase in cardiac output also contributed to the presser effect (Fig. 2) . Nicotine but not anatoxin-A induced a biphasic change in cardiac output~ preceding the increase, cardiac output was transiently decreased immediately after nicotine administration. The depressant effect could be due to vagal Stimulation ofthe heart since it was also accompanied by bradycardia (Fig. 1 ) . However, increased cardiac afterload due to pe- ripheral vasoconstriction also contributed to the reduced cardiac output since total peripheral resistance was significantly increased at the nadir of the cardiac depressant effect. Interestingly. anatoxin-A only increased cardiac output despite its bradycardic response. The increase in cardiac output, however, preceded the bradycardic response which probably was due to reflex vagal activation in response to peripheral vasoconstriction (Brezenoffand Giuliano, 1982) .
The hemodynamic effects ofintravenously administered anatoxin-A and nicotine were effectively blocked by the ganglion blocker chlorisondamine (Figs. 7 and 8 ) indicating that these effects were mediated by the nicotinic receptors in autonomic ganglia. Thus, our results corroborate the in vitro data that anatoxin-A is a potent nicotinic cholinergic agonist (Carmichael et al., 1979~ Swanson et al., 1986 Zhang et al .. 1987) . Activation of adrenal medulla was also evident by the increased Ievels of plasma epinephrine after anatoxin-A and nicotine administration ( 6). Paradoxically~ we found a striking difference in the potency of anatoxin-A versus nicotine to increase plasma catecholamine Ievels: nicotine was more than 1 0-fold more potent than anatoxin-A in provoking catecholamine release~ yet anatoxin-A seemed to stimulate selectively the adrenal medulla with virtually no effect on the sympathetic nerves since only plasma epinephrine but not norepinephrine Ievels were significantly elevated after anatoxin-A administration. Nicotine, on the other band, increased both plasma epinephrine and norepinephrine. Since in the rat 30-45% of the circulating norepinephrine is estimated to be derived from the adrenal medulla (Goldstein et al.. 1983; Sin~n et al., 1988) , the increase in plasma norepinephrine after nicotine is likely tobe due to an activation ofthe sympathetic nerves and adrenal medulla. Stimulation of the sympathetic nerves (as evidenced by the increase in plasma norepinephrine Ievel) probably also contributed to the strong vasoconstrictor effect and increased TPR seen immediately after nicotine but not anatoxin-A administration. These findings concur with the earlier studies which demonstrated dissociation of the pressor and adrenal catecholamine releasing effects of cholinomimetic drugs (see Brezenoff and Giuliano, 1982: Kaul and Grewal, 1972; Brezenoff, 1973) . Nonetheless, a role for adrenal catecholamines in mediating the hemodynamic responses to anatoxin-A cannot be excluded. Epinephrine released from adrenal medulla probably produced both vasodilator and vasoconstrictor responses (Sin~~n et al., 1988) which could account for the Iack of an initial vasoconstrictor response after anatoxin-A administration (Fig. 2) . Interestingly. the anatoxin-A dose of 100 ~g/kg produced only reflex bradycardia and not tachycardia like the corresponding dose of nicotine (Fig. 1 ) . Since tachycardia was shown to reflect reliably the alterations in sympathetic tonein situations in which the sympathoadrenomedullary system has been stimulated (Ricksten et al., 1984 ) , the Iack of a tachycardic response after anatoxin-A administrationfurther indicated a major role for the adrenal medulla rather than sympathetic nerves in mediation ofthe anatoxin-A effects. These findings thus imply that despite the critical role of ganglionic nicotine receptors in mediating the hemodynamic effects of anatoxin-A and nicotine, the mechanisms involved in the cardiovascular actions of these substances may not be entirely identical.
Intracerebroventricular administration of anatoxin-A and nicotine (30-1 00 J.Lg/kg) induced presser and splanchnic vasoconstrictor responses (Figs. 9 and 1 0) . Again, the mesenteric vasculature was the mostsensitive to the constrictor action of anatoxin-A and nicotine (Fig. 1 0) . Our results thus agree with and extend the previous finding that icv-administered acetylcholine or nicotine in the rat increase blood pressure with variable effect on the heart rate (see Brezenoff and Giuliano. 1982). In the anesthetized rat, intracisternal or icv administration of nicotine was reported to increase blood pressure (Kubo and Misu, 1980; Krstic and Djurkovic, 1978) . The cardiovascular effects of anatoxin-A in our study most likely were due to Stimulation of cholinergic nicotinic receptors since anatoxin-A was shown to bind to nicotine binding sites in the rat brain (Zhang et al., 1987) . The weaker potency of anatoxin-A as compared to nicotine to produce cardiovascular responses after icv administration might be due to the use of the racemic mixture of ( + )-and (-)-isomers of anatoxin-A rather than the pure (+)-isomer since in the rat brain the (+)-isomer of anatoxin-A was reported to readily displace nicotine from its high-affinity binding sites whereas the (-)-isomer only bound to the low-affinity site (Zhang et al., 1987) .
In summary, the present study demonstrates that the cardiovascular responses to anatoxin-A bear close resemblance to those of a nicotinic cholinergic agonist after both systemic and centrat nervaus system adminM istration in the conscious rat. Anatoxin-A and nicotine produced pressor and renosplanchnic vasoconstrictor responses and at high doses increased cardiac output. These effects were most probably mediated by activation of the nicotinic receptors in sympathetic ganglia and adrenal medulla. Interestingly, marked differences were found in the ability of anatoxin-A versus nicotine to stimulate the sympathoadrenomedullary axis. Since both nicotine and anatoxin-A bind preferentially to nicotinic cholinergic binding sites our data might imply that the nicotinic receptors in the adrenal medullaaredisparate from the nie~ tine receptors in sympathetic ganglia.
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